Detalhe da pesquisa
1.
Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routine.
BMC Biol
; 22(1): 43, 2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38378561
2.
Window-of-opportunity clinical trials for biomarker discovery in head and neck squamous cell carcinoma.
Curr Opin Oncol
; 35(3): 158-165, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36966501
3.
Phase I trial of copanlisib, a selective PI3K inhibitor, in combination with cetuximab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
Invest New Drugs
; 39(6): 1641-1648, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34322775
4.
Is Primary Poorly Differentiated Sarcomatoid Malignancy of the Parotid Gland Sarcomatoid Undifferentiated/Dedifferentiated Melanoma? Report of Three Unusual Cases Diagnosed by Fine-Needle Aspiration Combined with Histological, Immunohistochemical, and Molecular Analyses.
Acta Cytol
; 68(2): 107-120, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38437817
5.
Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trial.
Eur J Cancer
; 183: 152-161, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868056
6.
Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers.
Eur J Cancer
; 191: 112981, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37506588
7.
Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial.
Nat Commun
; 14(1): 3698, 2023 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37349318
8.
Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activity.
Sci Rep
; 13(1): 22524, 2023 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38110561
9.
["Immunotherapy in head and neck squamous cell carcinoma"]. / Traitement des tumeurs de la vessie par les inhibiteurs du contrôle immunitaire.
Rev Prat
; 71(4): 396-399, 2021 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-34161005
10.
Paradigm Change in First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.
Cancers (Basel)
; 13(11)2021 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34073885
11.
HDAC Inhibition to Prime Immune Checkpoint Inhibitors.
Cancers (Basel)
; 14(1)2021 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008230
12.
Genomic Alterations in Head and Neck Squamous Cell Carcinoma: Level of Evidence According to ESMO Scale for Clinical Actionability of Molecular Targets (ESCAT).
JCO Precis Oncol
; 5: 215-226, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34994597
13.
Liver tests increase on abiraterone acetate in men with metastatic prostate cancer: Natural history, management and outcome.
Eur J Cancer
; 129: 117-122, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32151941
14.
Pembrolizumab for the treatment of cervical cancer.
Expert Opin Biol Ther
; 19(9): 871-877, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31322926
15.
Ten-year outcome of curative "exclusive" chemotherapy in N0M0 squamous cell carcinoma of the larynx and pharynx with complete clinical response.
Head Neck
; 41(7): 2190-2196, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30706570
16.
Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study.
Lancet Haematol
; 6(1): e48-e57, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30528137
17.
Abiraterone in metastatic castration-resistant prostate cancer: Efficacy and safety in unselected patients.
Cancer Treat Res Commun
; 17: 37-42, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30347333
18.
[Medical management of cholangiocarcinomas in 2015]. / Traitements médicaux des cholangiocarcinomes en 2015.
Bull Cancer
; 103(4): 389-99, 2016 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-26922666
19.
Severe Cellular Immunodeficiency Triggered by the CDK4/6 Inhibitor Palbociclib.
Clin Breast Cancer
; 20(2): e192-e195, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32088132